Bevacizumab or Pemetrexed Disodium Alone or In Combination After Induction Therapy in Treating Patients With Advanced Non-Squamous Non-Small Cell Lung Cancer

NCT01107626 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1516

Enrollment

NETWORK

Sponsor class

Conditions

Lung Cancer

Interventions

DRUG: Paclitaxel
DRUG: Carboplatin
BIOLOGICAL: Bevacizumab
DRUG: Pemetrexed Disodium Heptahydrate

Sponsor

ECOG-ACRIN Cancer Research Group

Collaborators

[object Object]